A carregar...

Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer’s Disease

The discovery of biomarkers for the onset of Alzheimer’s disease (AD) is essential for disease modification strategies. To date, AD biomarker studies have focused on brain imaging and cerebrospinal fluid (CSF) changes in amyloid-β (Aβ) peptide and tau proteins. While reliable to an extent, this pane...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Alzheimer Res
Main Authors: Counts, Scott E., He, Bin, Prout, John G., Michalski, Bernadeta, Farotti, Lucia, Fahnestock, Margaret, Mufson, Elliott J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5827942/
https://ncbi.nlm.nih.gov/pubmed/26825093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!